128
     RDKit          2D

 16 15  0  0  1  0  0  0  0  0999 V2000
    5.6655   -0.0784    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.0930    0.3341    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.9509    1.1592    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.8075   -0.9034    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.2365   -0.9034    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.2365   -0.0784    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5220    0.3341    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.9509    0.3341    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8075   -0.0784    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 H   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 H   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 H   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 H   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 H   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 H   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 H   0  0  0  0  0  0  0  0  0  0  0  0
  1  8  1  0
  2  9  1  0
  3  8  2  0
  4  9  2  0
  6  5  1  1
  6  7  1  0
  6  8  1  0
  7  9  1  0
  1 10  1  0
  2 11  1  0
  5 12  1  0
  5 13  1  0
  6 14  1  0
  7 15  1  0
  7 16  1  0
M  END
>  <ALOGPS_LOGP>  (1) 
-3.52

>  <ALOGPS_LOGS>  (1) 
0.03

>  <ALOGPS_SOLUBILITY>  (1) 
1.42e+02 g/l

>  <DATABASE_ID>  (1) 
DB00128

>  <DATABASE_NAME>  (1) 
drugbank

>  <DRUGBANK_ID>  (1) 
DB00128

>  <DRUG_GROUPS>  (1) 
approved; nutraceutical

>  <EXACT_MASS>  (1) 
133.037507717

>  <FORMULA>  (1) 
C4H7NO4

>  <GENERIC_NAME>  (1) 
L-Aspartic Acid

>  <INCHI_IDENTIFIER>  (1) 
InChI=1S/C4H7NO4/c5-2(4(8)9)1-3(6)7/h2H,1,5H2,(H,6,7)(H,8,9)/t2-/m0/s1

>  <INCHI_KEY>  (1) 
CKLJMWTZIZZHCS-REOHCLBHSA-N

>  <JCHEM_ACCEPTOR_COUNT>  (1) 
5

>  <JCHEM_AVERAGE_POLARIZABILITY>  (1) 
11.284232994701322

>  <JCHEM_BIOAVAILABILITY>  (1) 
1

>  <JCHEM_DONOR_COUNT>  (1) 
3

>  <JCHEM_FORMAL_CHARGE>  (1) 
0

>  <JCHEM_GHOSE_FILTER>  (1) 
0

>  <JCHEM_IUPAC>  (1) 
(2S)-2-aminobutanedioic acid

>  <JCHEM_LOGP>  (1) 
-3.5037527551764525

>  <JCHEM_MDDR_LIKE_RULE>  (1) 
0

>  <JCHEM_NUMBER_OF_RINGS>  (1) 
0

>  <JCHEM_PHYSIOLOGICAL_CHARGE>  (1) 
-1

>  <JCHEM_PKA>  (1) 
5.113750094894903

>  <JCHEM_PKA_STRONGEST_ACIDIC>  (1) 
1.7025435921010494

>  <JCHEM_PKA_STRONGEST_BASIC>  (1) 
9.614153755159162

>  <JCHEM_POLAR_SURFACE_AREA>  (1) 
100.61999999999999

>  <JCHEM_REFRACTIVITY>  (1) 
26.5327

>  <JCHEM_ROTATABLE_BOND_COUNT>  (1) 
3

>  <JCHEM_RULE_OF_FIVE>  (1) 
1

>  <JCHEM_TRADITIONAL_IUPAC>  (1) 
L-aspartic acid

>  <JCHEM_VEBER_RULE>  (1) 
0

>  <MOLECULAR_WEIGHT>  (1) 
133.1027

>  <PRODUCTS>  (1) 
Aminosyn II; Aminosyn II 10%; Aminosyn II 10% With Electrolytes; Aminosyn II 15%; Aminosyn II 5% Inj; Aminosyn II 7% Injection; Aminosyn II 7% M In 10% Dextrose(dual Chamber); Aminosyn II 7% With 10% Dextrose; Aminosyn II 7% With 50% Dextrose; Aminosyn II 8.5% Injection; Aminosyn II 8.5% M In 20% Dextrose (dual Chamber); Aminosyn II 8.5% With 50% Dextrose; Aminosyn II In Dextrose Injection; Aminosyn II with Electrolytes; Aminosyn-PF; Aminosyn-PF 10%; Aminosyn-PF 7%; Clinisol; Novamine; Olimel 3.3% E; Olimel 4.4%; Olimel 4.4% E; Olimel 5.7%; Olimel 5.7% E; Periolimel 2.5% E; Plenamine; Premasol - sulfite-free (Amino Acid); Primene 10%; Primene 10%-liq IV; ProSol; TrophAmine; Vamin 18 Electrolyte-free; Vamin N

>  <SECONDARY_ACCESSION_NUMBERS>  (1) 
NUTR00016; EXPT01823

>  <SMILES>  (1) 
N[C@@H](CC(O)=O)C(O)=O

>  <SYNONYMS>  (1) 
(S)-2-aminobutanedioic acid; (S)-2-aminosuccinic acid; 2-Aminosuccinic acid; Aspartic acid; L-Asp; L-Asparagins√§ure; L-Aspartate

$$$$
